[ad_1]
After last week’s quarterly-results megastorm, second-quarter earnings season is roughly three-quarters of the way through.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...